INQ000587706 – Witness Statement provided by Stuart Mark Baddeley on behalf of GlaxoSmithKline plc, dated 23/05/2025.

  • Published: 13 October 2025
  • Type: Evidence
  • Module: Module 7

Witness Statement provided by Stuart Mark Baddeley on behalf of GlaxoSmithKline plc, dated 23/05/2025.

Download this document